Unraveling typical disease trajectories in multimorbid patients from birth to death

FHS
March 7, 2024
7:43 pm

In a recent study published in npj Digital Medicine, Complexity Science Hub researchers analyzed a comprehensive dataset of 44 million hospital stays in Austria.

Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy

It’s been a hard week for the psychedelics pioneer Rick Doblin. First, the Food and Drug Administration declined to approve the MDMA-assisted therapy for post-traumatic

August 17, 2024

Opinion | ‘You Don’t Just Shoot an Arrow at It’: What We Heard This Week

“You don’t just shoot an arrow at it … you throw a grenade, fire a torpedo, and drown it all at once.” — Natalie Callander,

December 9, 2024

Medicare is urged to monitor how rebates affect Part D drug spending, but agency demurs

The U.S. government should monitor the effect that rebates have on Medicare Part D plans and whether these discounts ultimately discourage some people from enrolling

September 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.